ArticleBMC women's health2025
Clinical effectiveness and side effect profile of contraceptive implant (Implanon) among women at Sulaimaniyah, Iraq: a cross-sectional study.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundContraception is an effective way to prevent unintended pregnancies that have a significant impact on women’s health and the budget of countries.
objectivesTo assess the clinical effectiveness and side-effect profile of progesterone implant as a contraceptive method among the participants. PATIENTS AND
methodsThis cross-sectional study recruited 101 patients who used a contraceptive implant, Sulaimaniyah, Iraq, from January 2022 to January 2025. Then, participants’ sociodemographic and medical data were collected using a self-structured questionnaire validated questionnaire (provided in the supplementary data). Then, the correlations between some variables were determined to find the effectiveness and side effects of the contraceptive implant.
resultsAbout 45.5% of women using a contraceptive implant were aged ≥ 35 years, and 36.6% were obese. The common side effects of the contraceptive implant were weight gain (24.8%), headache (23.8%), and loss of libido (19.8%). Most women had a contraceptive implant removed or intended to remove it (54.5%) within 3 years, mainly due to menstrual irregularities (43.6%). During the period when the contraceptive implant was in situ, there was no unintended pregnancy (0.0%), while 75% of women who wished to conceive after removal of the contraceptive implant got pregnant within the first 6 months of removal, indicating early return of fertility after discontinuation of this contraceptive method. Women aged 35 years or older with three or more children experienced significantly more side effects (p ≤ 0.05).
conclusionsContraceptive implant is considered a highly effective and safe method to be used in women of reproductive age, despite some side effects, and there was early return of fertility after discontinuation of Implanon in women wishing to conceive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.